Skip to content

North American Comfilcon A Clinical Study

North American Comfilcon A Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06902584
Enrollment
182
Registered
2025-03-30
Start date
2025-02-05
Completion date
2025-12-31
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia, Astigmatism, Presbyopia

Brief summary

The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.

Detailed description

The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population after 2 hours of wear.

Interventions

DEVICEcomfilcon A Sphere lens

2 hours of wear

2 hours of wear

DEVICEcomfilcon A Multifocal lens

2 hours of wear

DEVICEcomfilcon A Energys lens

2 hours of wear

Sponsors

Centre for Ocular Research & Education, Canada
CollaboratorOTHER
CooperVision International Limited (CVIL)
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 8 to 75 years (inclusive). 2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months. 3. At least occasional overnight wear in the last 12 months.

Exclusion criteria

1\. Current participation in a contact lens or contact lens care product clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Visual Performance (Visual Acuity)At the end of 2 hours of wearVisual Performance will be measured using logMAR * High contrast, high illumination distance VA * High contrast, high illumination near VA
Incidence of contact lens-related adverse eventsAt the end of 2 hours of wearIncidence of contact lens-related adverse events will be recorded from subjects

Countries

United States

Contacts

Primary ContactJose A Vega, OD,MSc,PhD
jvega2@coopervision.com9256402964
Backup ContactJill Woods, MSc,MCOptom
jwoods@uwaterloo.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026